$38.61
1.313.51%
Dern. MÀJ: Oct 5, 4:15 PM
$39.00
1.704.56%
BioLife Solutions (BLFS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2026) a publié ses dernières prévisions le $112.5M - $115M pour BioLife Solutions {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
Par rapport aux prévisions précédentes, {{newestDate}} {{directionSummary}} ses prévisions de chiffre d'affaires ont été revues à la baisse, passant d'une fourchette précédente de undefined à undefined.
undefined a publié undefined mises à jour de ses recommandations entre undefined et undefined. undefined
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.04 | $0.02 | $-0.01 | $-0.01 |
| Actual | $0.08 | $0.04 | $0.04 | $0.04 |
| Surprise | +110.0% | +100.0% | +500.0% | +500.0% |
| Revenue | ||||
| Estimate | $27.6M | $25.6M | $23.8M | $25.7M |
| Actual | $28.5M | $27.5M | $24.8M | $28.1M |
| Surprise | +3.26% | +7.27% | +3.94% | +9.05% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.06 | $0.07 | $0.03 | $0.03 |
| Revenue | ||||
| Consensus | $29.1M | $30.1M | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.08 | $0.04 | 110.0 % |
| Q1 | May 7, 2026 | $0.04 | $0.02 | 100.0 % |
| Q4 | Feb 26, 2026 | $0.04 | $-0.01 | 500.0 % |
| Q3 | Nov 6, 2025 | $0.04 | $-0.01 | 500.0 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $28.47M | $27.57M | 3.26 % |
| Q1 | May 7, 2026 | $27.50M | $25.64M | 7.27 % |
| Q4 | Feb 26, 2026 | $24.76M | $23.83M | 3.94 % |
| Q3 | Nov 6, 2025 | $28.07M | $25.74M | 9.05 % |